The Form 4 filing, an SEC report of insider stock activity, was filed on November 9, 2026. The two transactions were dated November 5, 2026. James P. Coyle is listed as executive vice president and president of Marketplace at OPENLANE (OPLN).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-05 |
| Date of Latest Transaction | 2026-11-05 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 70,755 |
| Price | $35.21 |
| Total Transaction Value | $2,491,601.13 |
| Insider | |
| Ticker Symbol | OPLN |
| Company | OPENLANE, Inc. |
| Insider Name | Coyle James P |
| Insider Title | EVP & President, Marketplace |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 58,884 |
| Position Size Change | 54.58% |
| Filing | |
| Filing Date | 2026-11-09 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were two share sales, reported under SEC transaction code S. A matching share count suggests a link to an exercise or conversion. That is a step that turns certain rights into shares.
What was the average price of the transaction?
The average sale price was $35.21 per share across the two transactions.
How did this transaction affect the insider's holdings?
He sold 70,755 shares and reported owning 58,884 shares afterward. The sales covered 54.58% of his reported shares owned before the sales.
What's the total transaction value?
The two sales had a total value of $2,491,601.13.
Are there any special circumstances around this transaction?
Yes. The sales appear linked to a code M exercise or conversion in the same filing. This link is based on matching share counts. Details of the related transaction and filing footnotes are not available.
The match does not confirm that the same shares were sold. It also does not confirm matching dates, share types, or accounts. How the exercise or conversion was paid for remains unknown. The information does not show whether the sales were required or covered taxes.
For research purposes only; not investment advice.